Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Midazolam for Sedation in Pediatric Inguinal Hernia Repair
NCT05337085Phase 1Unknown
- Sponsor
- Sheikh Zayed Medical College
- Start
- Jun 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, single-blind trial of dexmedetomidine in inguinal hernia (2 arms), sponsored by Sheikh Zayed Medical College. Primary endpoint: Ramsay Sedation Scale at 6 months. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on NCT05337085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05337085.